nach oben

Reviews in Endocrine and Metabolic Disorders

Erschienen in:

09.11.2016

Biomarkers of skin aging

verfasst von: Theodora Kanaki, Evgenia Makrantonaki, Christos C. Zouboulis

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Aging is a complex process not only influenced by inherited but also by several environmental factors. It is characterized by a progressive loss of function in multiple tissues, which leads to an increased probability of death. On the other hand, several morphological and histological changes are registered in aged skin that is mostly dependent on the cumulative exposure in environmental aging promoters, such as ultraviolet radiation. Understanding of individual pathogenesis and introduction of preventive measurements require objective assessment, i.e., the administration of biomarkers. Because of the complexity of skin aging, the exact definition of biomarkers is a major research challenge. In this article, we summarize the basic knowledge involving skin aging and its biomarkers.

Maroso EJ. Physiological system markers of aging. Exp Gerontol. 1988;23:391–4.CrossRef

Makrantonaki E, Brink TC, Zampeli V, Elewa RM, Mlody B, Hossini AM, et al. Identification of biomarkers of human skin ageing in both genders. Wnt signalling—a label of skin ageing? PLoS One. 2012;7, e50393.PubMedPubMedCentralCrossRef

Zahn JM, Kim SK. Systems biology of aging in four species. Curr Opin Biotechnol. 2007;18:355–9.PubMedPubMedCentralCrossRef

Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363–7.PubMedPubMedCentralCrossRef

Yaar M, Eller MS, Gilchrest BA. Fifty years of skin aging. J Investig Dermatol Symp Proc. 2002;7:51–8.PubMedCrossRef

Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc. 1990;65:375–98.PubMedCrossRef

Kirkwood TB. Genes that shape the course of ageing. Trends Endocrinol Metab. 2003;14:345–7.PubMedCrossRef

Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89:10114–8.PubMedPubMedCentralCrossRef

Smith JR, Pereira-Smith OM. Replicative senescence: implications for in vivo aging and tumor suppression. Science. 1996;273:63–7.PubMedCrossRef

10.

Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999;286:774–9.PubMedCrossRef

11.

Miquel J. An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp Gerontol. 1998;33:113–26.PubMedCrossRef

12.

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217.PubMedPubMedCentralCrossRef

13.

Gems D, Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol. 2013;75:621–44.PubMedCrossRef

14.

Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120:437–47.PubMedCrossRef

15.

Vijg J, Campisi J. Puzzles, promises and a cure for ageing. Nature. 2008;454:1065–71.PubMedPubMedCentralCrossRef

16.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.PubMedCrossRef

17.

Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008;7:3344–54.PubMedCrossRef

18.

McGrath JA, Eady RAJ, Pope FM. Anatomy and organization of human skin. In: Burns T, Breathnach S, Cox N, Griffiths C (eds) Rook’s Textbook of Dermatology. 8th Edition, 2013:Chapter 3.

19.

Makrantonaki E, Zouboulis CC. German National Genome Research Network 2. The skin as a mirror of the aging process in the human organism—state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol. 2007;42:879–86.PubMedCrossRef

20.

Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol. 2011;29:3–14.PubMedCrossRef

21.

Makrantonaki E, Bekou V, Zouboulis CC. Genetics and skin aging. Dermatol Endocrinol. 2012;4:280–4.CrossRef

22.

Makrantonaki E, Schönknecht P, Hossini AM, Kaiser E, Katsouli MM, Adjaye J, et al. Skin and brain age together: the role of hormones in the ageing process. Exp Gerontol. 2010;45:801–13.PubMedCrossRef

23.

Cordisco S, Maurelli R, Bondanza S, Stefanini M, Zambruno G, Guerra L, et al. Bmi-1 reduction plays a key role in physiological and premature aging of primary human keratinocytes. J Invest Dermatol. 2010;130:1048–62.PubMedCrossRef

24.

Navarro C, Cau P, Levy N. Molecular bases of progeroid syndromes. Hum Mol Genet. 2006;15:R151–61.PubMedCrossRef

25.

Nikolakis G, Makrantonaki E, Zouboulis CC. Skin mirrors human aging. Horm Mol Biol Clin Investig. 2013;16:3–28.

26.

Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci. 2007;1119:40–50.PubMedCrossRef

27.

Giangreco A, Qin M, Pintar JE, Watt FM. Epidermal stem cells are retained in vivo throughout skin aging. Aging Cell. 2008;7:250–9.PubMedPubMedCentralCrossRef

28.

Aronson J. Biomarkers and surrogate endpoints. Br J Clin Pharmacol. 2005;59:491–4.PubMedPubMedCentralCrossRef

29.

Kyle S, Tavel J. What are biomarkers? Curr Opin HIV AIDS. 2010;5:463–6.CrossRef

30.

Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Therapeut. 2001;69:89–95.CrossRef

31.

Baker 3rd GT, Sprott RL. Biomarkers of aging. Exp Gerontol. 1988;23:223–39.PubMedCrossRef

32.

WHO International Programm on Chemical Safety Biomarkers in Risk Assessment. Validity and Validation. 2001 (http://www.inchem.org/documents/ehc/ehc/ehc222.htm).

33.

Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science. 2006;311:1257.PubMedCrossRef

34.

Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007;128:36–44.PubMedCrossRef

35.

Passarge E. Color atlas of genetics. Stuttgart: Thieme; 2007.

36.

Jiang H, Ju Z, Rudolph KL. Telomere shortening and ageing. Z Gerontol Geriatr. 2007;40:314–24.PubMedCrossRef

37.

Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev. 2008;129:467–74.PubMedPubMedCentralCrossRef

38.

Sfeir AJ, Chai W, Shay JW, Wright WE. Telomere-end processing the terminal nucleotides of human chromosomes. Mol Cell. 2005;18:131–8.PubMedCrossRef

39.

Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–52.PubMedCrossRef

40.

Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol. 2002;20:682–8.PubMedCrossRef

41.

Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 2001;107:67–77.PubMedCrossRef

42.

d’Adda di Fagagna F, Teo SH, Jackson SP. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 2004;18:1781–1799.

43.

von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med. 2005;5:197–203.CrossRef

44.

Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev. 2006;127:16–24.PubMedCrossRef

45.

d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426:194–198.

46.

Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol. 2003;13:1549–56.PubMedCrossRef

47.

Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell. 2004;14:501–13.PubMedCrossRef

48.

Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106:661–73.PubMedCrossRef

49.

Drayton S, Peters G. Immortalisation and transformation revisited. Curr Opin Genet Dev. 2002;12:98–104.PubMedCrossRef

50.

Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 1998;16:1113–23.PubMedCrossRef

51.

Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4:1798–806.PubMedCrossRef

52.

Severino J, Allen RG, Balin S, Balin A, Cristofalo VJ. Is beta- galactosidase staining a marker of senescence in vitro and in vivo? Exp Cell Res. 2000;257:162–71.PubMedCrossRef

53.

Cristofalo VJ. SA beta Gal staining: biomarker or delusion. Exp Gerontol. 2005;40:836–8.PubMedCrossRef

54.

Yang NC, Hu ML. The limitations and validities of senescence associated-beta-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells. Exp Gerontol. 2005;40:813–9.PubMedCrossRef

55.

Yegorov YE, Akimov SS, Hass R, Zelenin AV, Prudovsky IA. Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp Cell Res. 1998;243:207–11.PubMedCrossRef

56.

Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 2006;5:187–95.PubMedCrossRef

57.

Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299–307.PubMedPubMedCentralCrossRef

58.

Campisi J. d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729–40.PubMedCrossRef

59.

Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479:232–6.PubMedPubMedCentralCrossRef

60.

Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol. 2011;192:547–56.PubMedPubMedCentralCrossRef

61.

Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Curr Biol. 1999;9:939–45.PubMedCrossRef

62.

Vo TK, de Saint-Hubert M, Morrhaye G, Godard P, Geenen V, Martens HJ, et al. Transcriptomic biomarkers of the response of hospitalized geriatric patients admitted with heart failure. Comparison to hospitalized geriatric patients with infectious diseases or hip fracture. Mech Ageing Dev. 2011;132:131–9.PubMedCrossRef

63.

Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.PubMedCrossRef

64.

Yu BP, Yang R. Critical evaluation of the free radical theory of aging. A proposal for the oxidative stress hypothesis. Ann N Y Acad Sci. 1996;786:1–11.PubMedCrossRef

65.

Kim YJ, Yokozawa T, Chung HY. Effects of energy restriction and fish oil supplementation on renal guanidino levels and antioxidant defences in aged lupus-prone B/W mice. Br J Nutr. 2005;93:835–44.PubMedCrossRef

66.

Sohal RS, Orr WC. The redox stress hypothesis of aging. Free Radic Biol Med. 2012;52:539–55.PubMedCrossRef

67.

Marzetti E, Hwang JC, Lees HA, Wohlgemuth SE, Dupont-Versteegden EE, Carter CS, et al. Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta. 1800;2010:235–44.

68.

Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333:1109–12.PubMedPubMedCentralCrossRef

69.

Ishitsuka Y, Maniwa F, Koide C, Kato Y, Nakamura Y, Osawa T, et al. Increased halogenated tyrosine levels are useful markers of human skin ageing, reflecting proteins denatured by past skin inflammation. Clin Exp Dermatol. 2012;37:252–8.PubMedCrossRef

70.

Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem. 1995;270:16542–8.PubMedCrossRef

71.

Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997;99:2075–81.PubMedPubMedCentralCrossRef

72.

Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–36.PubMedCrossRef

73.

Gilchrest BA. In vitro assessment of keratinocyte aging. J Invest Dermatol. 1983;81:184s–9s.PubMedCrossRef

74.

Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A. 1976;73:3584–8.PubMedPubMedCentralCrossRef

75.

Mets T, Bekaert E, Verdonk G. Similarity between in vitro and in vivo cellular aging. Mech Ageing Dev. 1983;22:71–8.PubMedCrossRef

76.

Cristofalo VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev. 1993;73:617–38.PubMed

77.

Gilchrest BA, Vrabel MA, Flynn E, Szabo G. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol. 1984;83:370–6.PubMedCrossRef

78.

Harman D. Role of free radicals in aging and disease. Ann N Y Acad Sci. 1992;673:126–41.PubMedCrossRef

79.

Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120:483–95.PubMedCrossRef

80.

Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994;91:10771–8.PubMedPubMedCentralCrossRef

81.

Lu T, Finkel T. Free radicals and senescence. Exp Cell Res. 2008;314:1918–22.PubMedPubMedCentralCrossRef

82.

Lu CY, Lee HC, Fahn HJ, Wei YH. Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin. Mutat Res. 1999;423:11–21.PubMedCrossRef

83.

Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med. 2009;47:344–56.PubMedPubMedCentralCrossRef

84.

Velarde MC, Flynn JM, Day NU, Melov S, Campisi J. Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypesin the skin. Aging (Albany NY). 2012;4:3–12.CrossRef

85.

Hruszkewycz AM. Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem Biophys Res Commun. 1988;153:191–7.PubMedCrossRef

86.

Hruszkewycz AM, Bergtold DS. The 8-hydroxyguanine content of isolated mitochondria increases with lipid peroxidation. Mutat Res. 1990;244:123–8.PubMedCrossRef

87.

Waaijer ME, Parish WE, Strongitharm BH, van Heemst D, Slagboom PE, de Craen AJ, et al. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012;11:722–5.PubMedPubMedCentralCrossRef

88.

Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol. 2007;26:587–96.PubMedPubMedCentralCrossRef

89.

Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–73.PubMedCrossRef

90.

Sárdy M. Role of matrix metalloproteinases in skin ageing. Connect Tissue Res. 2009;50:132–8.PubMedCrossRef

91.

Kazi M, Geraci SA, Koch CA. Considerations for the diagnosis and treatment of testosterone deficiency in elderly men. Am J Med. 2007;120(10):835–40.PubMedCrossRef

92.

Roth J, Koch CA, Rother KI. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 4th ed. Philadelphia: WB Saunders; 2001. p. 529–55.

93.

Alesci S, Koch CA, Bornstein SR, Pacak K. Adrenal androgens regulation and adrenopause. Endocr Regul. 2001;35(2):95–100.PubMed

94.

Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–4.PubMedCrossRef

95.

Gloth 3rd FM, Gundberg CM, Hollis BW, Haddad Jr JG, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995;274(21):1683–6.PubMedCrossRef

96.

McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab. 1996;81(5):1699–703.PubMed

97.

Avioli LV, McDonald JE, Lee SW. The influence of age on the intestinal absorption of 47-Ca absorption in post-menopausal osteoporosis. J Clin Invest. 1965;44(12):1960–7.PubMedPubMedCentralCrossRef

98.

Slovik DM, Adams JS, Neer RM, Holick MF, Potts Jr JT. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med. 1981;305(7):372–4.PubMedCrossRef

99.

Gloth 3rd FM, Tobin JD. Vitamin D deficiency in older people. J Am Geriatr Soc. 1995;43(7):822–8.PubMedCrossRef

100.

Makrantonaki E, Vogel K, Fimmel S, Oeff M, Seltmann H, Zouboulis CC. Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol. 2008;43:939–46.PubMedCrossRef

101.

Elewa RM, Abdallah M, Youssef N, Zouboulis CC. Aging-related changes in cutaneous corticotropin-releasing hormone system reflect a defective neuroendocrine-stress response in aging. Rejuvenation Res. 2012;15:366–73.PubMedCrossRef

102.

Elewa RM, Abdallah MA, Zouboulis CC. Age-associated skin changes in innate immunity markers reflect a complex interaction between aging mechanisms in the sebaceous gland. J Dermatol. 2015;42:467–76.PubMedCrossRef

103.

Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1–6.PubMedCrossRef

104.

Rittié L, Kang S, Voorhees JJ, Fisher GJ. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo. Arch Dermatol. 2008;144:1129–40.PubMedCrossRef

105.

Fuchs KO, Solis O, Tapawan R, Paranjpe J. The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: a randomized histologic study. Cutis. 2003;71:481–8.PubMed

106.

Patriarca MT, Goldman KZ, Dos Santos JM, Petri V, Simões RS, Soares Jr JM, et al. Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study. Eur J Obstet Gynecol Reprod Biol. 2007;130:202–5.PubMedCrossRef

107.

Sator PG, Schmidt JB, Sator MO, Huber JC, Hönigsmann H. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas. 2001;39:43–55.PubMedCrossRef

108.

Sator PG, Sator MO, Schmidt JB, Nahavandi H, Radakovic S, Huber JC, et al. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric. 2007;10:320–34.PubMedCrossRef

Titel: Biomarkers of skin aging
verfasst von: Theodora Kanaki
Evgenia Makrantonaki
Christos C. Zouboulis
Publikationsdatum: 09.11.2016
Verlag: Springer US
Erschienen in: Reviews in Endocrine and Metabolic Disorders / Ausgabe 3/2016
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-016-9392-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

17.04.2024 | DGIM 2024 | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Biomarkers of skin aging

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Delir kann Demenz begünstigen

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Flushing in (neuro)endocrinology

Skin steroidogenesis in health and disease

Neuroendocrinology of the skin

Beyond acne: Current aspects of sebaceous gland biology and function

Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook

Hereditary syndromes predisposing to endocrine tumors and their skin manifestations

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Delir kann Demenz begünstigen

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Innere Medizin